HBOT for TBI: Does Hyperbaric Oxygen Therapy Help Recovery?
In 2023-24, UK hospitals recorded 123,969 admissions for head injury, roughly one every four minutes [14]. Most people recover, but some live with lasting symptoms. That gap explains growing interest in HBOT for TBI (Hyperbaric Oxygen Therapy for Traumatic Brain Injury).
Can HBOT help TBI? Research into hyperbaric oxygen for brain injury is an area of active clinical investigation. Some small trials report gains, but sham-controlled trials and a Cochrane review do not support routine use. The Undersea and Hyperbaric Medical Society (UHMS) does not recognise it as an approved indication.
This review explains what traumatic brain injury is and how hyperbaric oxygen might act on it. It then weighs positive and null trials, protocols, safety, and UK and European status. Written for patients, carers and clinicians, it is educational only. The full medical disclaimer appears in the safety section and again at the end.
Medical Disclaimer: This article is for general informational and educational purposes only. It does not constitute medical advice. Always consult a qualified GP or healthcare professional before considering HBOT, particularly if you have any pre-existing medical conditions, are pregnant, or are undergoing medical treatment.
Table of Contents
1. What Is Traumatic Brain Injury?
Traumatic brain injury (TBI) is damage to the brain caused by an external force, such as a fall, road collision, assault or sports impact. Doctors grade it as mild, moderate or severe. They often use the Glasgow Coma Scale (GCS), a 3 to 15 score of eye, speech and movement responses.
UK Numbers
Headway, the UK brain injury charity, counted 335,409 hospital admissions for acquired brain injury in 2023-24, about 919 per day. Males were 1.5 times more likely than females to be admitted for head injury [14]. Admissions are not individual people, because one person can be admitted more than once.
What happens inside the brain
The first impact causes direct damage. Over the following hours and days, secondary injury develops. This includes swelling, reduced blood flow, brain inflammation and low oxygen delivery to tissue. Many proposed treatments target this second stage.
Persistent symptoms after concussion
Most people with mild TBI (concussion) recover within weeks. A minority keep headaches, poor concentration, sleep problems and low mood for months or years. Researchers call this post-concussion syndrome. One 2013 trial team estimated that up to 25% of people with mild TBI develop prolonged symptoms [5].
The National Institute for Health and Care Excellence (NICE) publishes guideline NG232 on head injury. It covers assessment and early management, including CT scanning and referral to specialist care. It does not cover HBOT for TBI [16].
2. How Does HBOT Relate to Brain Injury?
HBOT (Hyperbaric Oxygen Therapy) may act on TBI by raising tissue oxygen and easing inflammation, but this remains a hypothesis. Hyperbaric oxygen treatment means breathing near-pure oxygen inside a pressurised chamber. Pressure is measured in atmospheres absolute (ATA), where 1 ATA equals normal sea-level pressure. Extra pressure dissolves more oxygen into blood plasma, so it can reach tissue with a poor blood supply.
HBOT and brain health: proposed mechanisms
Researchers have suggested that hyperbaric oxygen therapy may help in several ways:
Better oxygen delivery to under-supplied brain tissue
Less swelling and brain inflammation
New blood vessel growth, called angiogenesis
Support for neuroplasticity, the brain's ability to form new connections
A 2013 trial team proposed that HBOT repairs chronically impaired brain function in mild TBI [5]. The NIH-funded HOBIT trial summary cites preclinical work on reduced inflammation and apoptosis (cell death) [15]. These mechanisms come from lab and small clinical studies. Human trials have not proved them.
Hyperbaric chamber brain injury studies have used monoplace (single-person) and multiplace (group) chambers. A 2017 review found five trials in multiplace chambers and three in monoplace chambers, and none compared the two [9]. Oxygen therapy TBI research also tests normobaric hyperoxia, meaning oxygen at normal pressure, which HOBIT gives after hyperbaric sessions [15].
Evidence Note: A plausible mechanism does not prove a treatment works. Sham-controlled trials test that question directly for HBOT for TBI.
Why pressure and dose matter
HBOT combines two variables: higher pressure and higher oxygen. A 2022 review argued that pressure within a narrow range matters more than oxygen concentration [10]. The author declared co-ownership of a hyperbaric service company, and other reviewers disagree.
UHMS defines clinical HBOT as a pressure of not less than 2.0 ATA in a hard-sided chamber. It calls "mild" treatment below 1.5 ATA unproven [12]. Most TBI trials sit at or below that threshold, which complicates comparison.
3. Does HBOT Help TBI? What the Research Shows
Evidence is mixed: small trials without sham controls report gains, while most sham-controlled trials found no difference from sham. The sections below cover status, positive findings, null results and ongoing trials. This narrative review used targeted searches of PubMed, PubMed Central, Cochrane and society sources in October 2026. It is not a systematic review.
UHMS, NHS and ECHM status
Research into HBOT for TBI represents an area of active clinical investigation. This is not a UHMS-recognised indication, and the evidence continues to develop and larger trials are ongoing. UHMS notes that one positive trial at 1.5 ATA exists, but considers such treatment investigational [12].
The European Committee for Hyperbaric Medicine (ECHM) held a 10th consensus conference. It rated brain injury as a Type 3 (optional) indication with Level B evidence. That covers acute moderate-severe TBI and highly selected chronic cases with clearly dysfunctional brain regions. ECHM also issued a Type 1 recommendation that TBI treatment occur only within an ethics-approved investigational protocol [11].
NHS England commissions HBOT for two indications only: decompression illness and gas embolism. TBI is not among them [13].
Positive Findings
A 2013 randomised crossover trial in PLoS ONE analysed 56 adults with mild TBI 1 to 5 years earlier. They received 40 sessions at 1.5 ATA, and cognitive function and quality of life improved after HBOT but not during the untreated control period. The authors used no sham group, so expectation effects remain possible. Later sham-controlled trials have not consistently reproduced this result [5].
A 2020 randomised crossover trial in Medical Gas Research enrolled 63 civilian and military participants. They received 40 sessions at 150 kPa (about 1.5 ATA) or an untreated control period, and 50 completed testing. Symptoms, memory, sleep and quality of life improved versus controls. The control arm received no sham, and the study was small [6].
A 2025 double-blind trial in Scientific Reports randomised 47 adults with persistent symptoms after non-stroke brain injury, 40 of them with TBI. After 40 sessions at 1.5 ATA, symptom scores improved by 10.6 points versus 3.6 with sham. The 7.0 point difference was significant (95% CI 1.7-12.3, p = 0.01). Both arms improved, the sample was small, and the confidence interval was wide [7].
For acute moderate TBI, a randomised trial in Asian Journal of Neurosurgery tested 10 daily 60-minute sessions at 1.4 ATA alongside standard care. Mean discharge GCS was 14.37 versus 13.40 (p < 0.001), and 3-month Extended Glasgow Outcome Scale (GOS-E) scores were also higher. The abstract does not report sample size or blinding, and no replication is known [8].
Key Finding: The 2025 sham-controlled trial is the most recent positive signal. It remains a single small study and needs independent replication.
Mixed and Null Results
Not all studies have shown consistent benefit. The 2015 HOPPS trial in JAMA Internal Medicine randomised 72 service members with symptoms at least 4 months after mild TBI. They received 40 sessions at 1.5 ATA, 40 sham sessions (room air at 1.2 ATA), or no chamber. HBOT did not beat sham (P = .70), though both chamber groups improved versus care alone. The authors suggested nonspecific effects may explain this [2].
A 2014 sham-controlled trial of 60 service members in the Journal of Head Trauma Rehabilitation used 40 sessions over 10 weeks. Oxygen exposure equalled surface air, 1.5 ATA or 2.0 ATA oxygen, and the authors found no efficacy for HBOT. They noted scattered within-group gains could reflect nonspecific effects [3].
A 2012 trial in the Journal of Neurotrauma gave 50 service members 30 sessions over 8 weeks. They received either 2.4 ATA oxygen or sham air at 1.3 ATA. It found no significant difference, and both groups improved [4].
A 2017 systematic review in the Journal of Head Trauma Rehabilitation covered 12 randomised trials. For mild TBI, the four trials (250 participants) showed no significant difference from sham. For acute moderate-to-severe TBI (seven trials, 486 participants), results mostly favoured HBOT versus standard care, but quality was mixed [9].
The 2012 Cochrane review pooled 7 trials with 571 people. HBOT may reduce the risk of death (risk ratio 0.69) and raise final GCS, but there was little evidence that survivors had a good outcome. About 13% of the HBOT group had significant pulmonary impairment, versus 0% of controls. The authors concluded that routine use cannot be justified [1].
Key Finding: Sham-controlled trials show gains in both chamber groups. That raises the question of how much improvement comes from the chamber session itself, such as rest, attention and expectation.
Current and ongoing clinical trials
The US HOBIT trial is testing hyperbaric oxygen in severe TBI to find the best treatment parameters. By July 2024 it had enrolled 127 of a maximum 200 participants. An interim analysis after 116 enrolments reached no efficacy or futility criteria [15].
4. Is Hyperbaric Oxygen for TBI Available in the UK?
No. The NHS does not commission hyperbaric oxygen for TBI, and no NICE guidance covers it. Searches for hyperbaric oxygen treatment TBI UK often assume NHS access. In practice, HBOT for TBI is not commissioned in England, because the NHS England specification covers only decompression illness and gas embolism. It also defines HBOT as not less than 2.8 ATA [13].
At European level, the ECHM Code of Good Practice sets minimum standards for hyperbaric facilities. It says the term HBOT applies only when oxygen partial pressure exceeds 1.5 ATA [17]. Trial protocols at 1.5 ATA therefore sit at the edge of that definition.
The ECHM consensus supports TBI use only in ethics-approved studies [11]. Anyone in the UK should discuss options with their GP or neurologist.
5. What Treatment Protocols Do TBI Studies Use?
Most mild TBI trials used 1.5 ATA, 60-minute sessions and 40 sessions in total. These are protocols used in research settings, not treatment advice.
Pressure Levels in Hyperbaric Chamber Brain Injury Trials
Trials of chronic mild TBI mostly used 1.5 ATA, with 2.0 and 2.4 ATA in the null sham-controlled trials. The 2022 dosage review reported symptom benefit at 1.5 ATA but mixed results at other doses [10]. Sham designs differed, from room air at 1.2 ATA to 1.3 ATA, which complicates comparison.
Session Numbers in Oxygen Therapy TBI Trials
Most mild TBI trials delivered 40 daily sessions of 60 minutes, five days a week, over 8 to 12 weeks. In the 2025 trial, participants who then received 40 more sessions reported further improvement at 12 months. The authors suggested 80 sessions may outperform 40 [7]. That secondary finding was not blinded.
6. Is HBOT Safe? Risks and Contraindications
HBOT is generally well tolerated in trials, but it carries real risks and needs medical screening. Safety data come mostly from small trials in hospitals and military facilities. Reviews of TBI trials report ear pain and barotrauma (pressure injury), sinus squeeze, claustrophobia, headache, nausea and temporary short-sightedness. In moderate-to-severe TBI studies, seizures and pulmonary complications were also reported [9].
Absolute contraindication: untreated pneumothorax (collapsed lung). Relative contraindications generally include severe lung disease, uncontrolled epilepsy, recent ear or chest surgery, high fever and some medications. Pregnancy needs specialist advice. People with TBI may have skull fractures, sinus damage or seizure risk, so medical supervision is essential.
Medical disclaimer: This article is for general informational and educational purposes only. It does not constitute medical advice. Hyperbaric oxygen chambers supplied by Hyperbaric Oxygen Treatment UK are wellness and professional equipment, not MHRA-regulated medical devices for the treatment of disease. Always consult a qualified GP or healthcare professional before considering HBOT, particularly if you have any pre-existing medical conditions, are pregnant, or are undergoing medical treatment.
7. Who Is Exploring Hyperbaric Oxygen for Brain Injury?
The largest sham-controlled trials enrolled US service members with mild TBI. Those programmes included HOPPS [2]. Civilian groups study road injury, falls and assault-related harm. Neurologists and rehabilitation specialists follow this work, though few advise HBOT for TBI outside research.
HBOT for Concussion in Sport and Military Settings
Interest in HBOT for concussion comes mainly from athletes, veterans and people with long-running symptoms. That evidence is mostly military trials, as described above. These groups often report that standard rehabilitation has plateaued. Their experience is a reason for more trials, not proof of benefit.
Interest in brain health HBOT also extends to people without injury, and HBOT for TBI trials never tested that group. No trial cited here tested healthy people, so those claims have no support from this evidence.
Anyone weighing HBOT for TBI should first ask a doctor about concussion recovery options, including standard rehabilitation [16]. Online communities contain strong personal claims, but anecdotes cannot separate treatment effects from natural recovery.
8. Frequently Asked Questions About HBOT and TBI
Q. Is HBOT an approved treatment for TBI?
A. No, it is not a UHMS-recognised or NHS-commissioned indication. UHMS considers HBOT for TBI investigational, and ECHM rates it as optional in selected patients within ethics-approved studies [12].
Q. Does HBOT help TBI?
A. For HBOT for TBI, the evidence is mixed. Open-label and crossover trials report gains, while three sham-controlled military trials found no difference from sham, and one 2025 sham-controlled trial found benefit [7].
Q. What pressure levels are used in research for TBI?
A. Most chronic mild TBI trials used 1.5 ATA. Others tested 1.4 to 2.4 ATA [10].
Q. How many sessions of HBOT for TBI have been studied?
A. Most trials used 40 sessions of about 60 minutes. A moderate TBI trial used 10 daily sessions, and one study explored 80 sessions [8].
Q. Is HBOT safe if you have TBI?
A. It is generally well tolerated in trials, but risks include barotrauma, seizures and lung problems. Individual assessment by a doctor is essential [9].
Q. Is HBOT available on the NHS for TBI?
A. No. For hyperbaric oxygen treatment TBI UK enquiries, note that NHS England commissions HBOT only for decompression illness and gas embolism [13].
Q. Can HBOT be used at home for TBI?
A. This article cannot recommend home use. UHMS describes treatment below 1.5 ATA as unproven, and ECHM supports TBI use only in ethics-approved studies. Read frequently asked questions about hyperbaric oxygen therapy → and speak to your doctor.
Q. What should I ask my doctor before trying HBOT?
A. Ask about safety for your injury type, the evidence for your symptoms, and which rehabilitation to continue. Five questions to bring:
Is HBOT safe given my injury, seizure history, and sinus or lung health?
What does the evidence say for my type and stage of injury?
Is there a registered trial I could join instead?
Which standard rehabilitation should I continue alongside it?
What would we measure to know whether it helped?
Q. Does brain health HBOT work for people without an injury?
A. No trial cited in this review tested healthy people, so there is no supporting evidence here. Every study enrolled people with diagnosed brain injury or post-concussion syndrome [9].
Q. Why do sham groups improve too?
A. Likely explanations include expectation, attention, rest and small effects from mild pressure. Both chamber groups in HOPPS improved compared with standard care alone [2].
9. Summary of Current Evidence
Key takeaways:
Supported: Small trials and one 2025 sham-controlled trial report gains after mild TBI at about 1.5 ATA.
Uncertain: Three earlier sham-controlled trials found no difference, and Cochrane found routine use unjustified.
Ongoing: HOBIT is testing severe TBI.
Some small trials report better symptoms and cognitive function after mild TBI with HBOT at about 1.5 ATA, and a 2025 sham-controlled trial supports this. Three earlier sham-controlled military trials found no difference from sham, and Cochrane concluded routine use cannot be justified. Cochrane also reported fewer deaths in acute injury, with little evidence of good outcomes in survivors. Evidence for acute moderate-to-severe injury is older and lower quality, and HOBIT may clarify it.
Research into HBOT for TBI remains an area of active clinical investigation, and HBOT for concussion sits in the same category. UHMS considers it investigational, ECHM limits it to ethics-approved studies, and the NHS does not commission it. Open questions about HBOT for TBI include the best pressure, the number of sessions and which patients might benefit.
Medical Disclaimer: This article is for general informational and educational purposes only. It does not constitute medical advice. Hyperbaric oxygen chambers supplied by Hyperbaric Oxygen Treatment UK are wellness and professional equipment, not MHRA-regulated medical devices for the treatment of disease. Always consult a qualified GP or healthcare professional before considering HBOT, particularly if you have any pre-existing medical conditions, are pregnant, or are undergoing medical treatment.
This research review is published by Hyperbaric Oxygen Treatment UK, a specialist hyperbaric chamber supplier and installer based in Cleveleys, Lancashire, UK, with 120+ chamber installations across the UK, Europe, and internationally. Member of the International Board of Undersea Medicine (IBUM) and the International Hyperbarics Association (IHA). Information about available HBOT equipment for clinical and home environments can be found at hyperbaricoxygentreatment.uk.
10. References & Medical Sources
Bennett MH, Trytko B, Jonker B. "Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury." Cochrane Database of Systematic Reviews, 2012;12:CD004609. https://pubmed.ncbi.nlm.nih.gov/23235612/
Miller RS, Weaver LK, Bahraini N, et al. "Effects of hyperbaric oxygen on symptoms and quality of life among service members with persistent postconcussion symptoms: a randomized clinical trial." JAMA Internal Medicine, 2015. https://pubmed.ncbi.nlm.nih.gov/25401463/
Cifu DX, Hart BB, West SL, Walker W, Carne W. "The effect of hyperbaric oxygen on persistent postconcussion symptoms." Journal of Head Trauma Rehabilitation, 2014. https://pubmed.ncbi.nlm.nih.gov/24052094/
Wolf G, Cifu D, Baugh L, Carne W, Profenna L. "The effect of hyperbaric oxygen on symptoms after mild traumatic brain injury." Journal of Neurotrauma, 2012. https://pubmed.ncbi.nlm.nih.gov/23031217/
Boussi-Gross R, Golan H, Fishlev G, et al. "Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury - randomized prospective trial." PLoS ONE, 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3829860/
Harch PG, Andrews SR, Rowe CJ, et al. "Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial." Medical Gas Research, 2020. https://pubmed.ncbi.nlm.nih.gov/32189664/
Weaver LK, Ziemnik R, Deru K, et al. "A double-blind randomized trial of hyperbaric oxygen for persistent symptoms after brain injury." Scientific Reports, 2025. https://doi.org/10.1038/s41598-025-86631-6
Chaturvedi J, et al. "Hyperbaric oxygen therapy (HBOT) in moderate traumatic brain injury (TBI): a randomized controlled trial." Asian Journal of Neurosurgery, 2025. https://pubmed.ncbi.nlm.nih.gov/40041595/
Crawford C, Teo L, Yang E, Isbister C, Berry K. "Is hyperbaric oxygen therapy effective for traumatic brain injury? A rapid evidence assessment of the literature and recommendations for the field." Journal of Head Trauma Rehabilitation, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5426690/
Harch PG. "Systematic review and dosage analysis: hyperbaric oxygen therapy efficacy in mild traumatic brain injury persistent postconcussion syndrome." Frontiers in Neurology, 2022. https://pubmed.ncbi.nlm.nih.gov/35370898/
Mathieu D, Marroni A, Kot J. "Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment." Diving and Hyperbaric Medicine, 2017. https://www.achobel.be/Download/DHM%202017%20-%20Mathieu%20-%2010th%20ECHM%20Consensus%20Conference%20Recommendations%20on%20HBO.pdf
Undersea and Hyperbaric Medical Society. "Indications for Hyperbaric Oxygen Therapy," 2020. https://uhms.org/resources/featured-resources/hbo-indications.html
NHS England. "Hyperbaric oxygen therapy services (all ages): service specification," January 2025. https://www.england.nhs.uk/wp-content/uploads/2018/11/Hyperbaric-oxygen-therapy-services-all-ages-Service-specification-January-2025.pdf
Headway - the brain injury association. "Statistics" (UK ABI hospital admissions 2023-24). https://www.headway.org.uk/about-brain-injury/further-information/statistics/
NIH RePORTER. "Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial," project 2U01NS095926-06. https://reporter.nih.gov/project-details/11144113
NICE. "Head injury: assessment and early management," NG232, 2023. https://www.nice.org.uk/guidance/ng232
European Committee for Hyperbaric Medicine. "A European code of good practice for hyperbaric oxygen therapy." https://pmc.ncbi.nlm.nih.gov/articles/PMC10911829/
Comments